Details for Patent: 6,589,959

✉ Email this page to a colleague

Summary for Patent: 6,589,959

Patent landscape, scope, and claims:

Title:	Crystalline bis[(e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]p yrimidin-5-yl](3R,5S)-3,5-dihydroxyhept-6-enoic acid]calcium salt
Abstract:	The present invention relates to a crystalline form of the compound bis[(E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]p yrimidin-5-yl](3R,5S)-3,5-dihydroxyhept-6-enoic acid]calcium salt, as well as processes for its manufacture and pharmaceutical compositions comprising the crystalline form, which is useful as an agent for treating hyperlipidemia, hypercholesterolemia and atherosclerosis.
Inventor(s):	Taylor; Nigel P (Macclesfield, GB)
Assignee:	Astrazeneca AB (Sodertalje, SE)
Application Number:	09/869,462
Patent Claim Types: see list of patent claims	Compound; Composition;
More… ↓ ⤷ Subscribe

Drugs Protected by US Patent 6,589,959

Glossary

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 6,589,959

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
United Kingdom	9900339	Jan 09, 1999

PCT Information
PCT Filed	December 23, 1999	PCT Application Number:	PCT/GB99/04439
PCT Publication Date:	July 20, 2000	PCT Publication Number:	WO00/42024

International Family Members for US Patent 6,589,959

Subscribe to access the full database, or Subscribe
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	282027	⤷ Subscribe
Australia	1882600	⤷ Subscribe
Australia	762909	⤷ Subscribe
Brazil	9916786	⤷ Subscribe
Canada	2356212	⤷ Subscribe
China	1213033	⤷ Subscribe
China	1333756	⤷ Subscribe
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.